eNauka - pregled

Pregled prema Autor Schadendorf, Dirk

Prikaz rezultata 1 do 3 od 3
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2024Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trialSchadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijusković, Željko P.  ; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study.Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijuskovic, Željko P  ; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2024Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world studyAsher, Nethanel; Mohr, Peter; Ellebaek, Eva; Bender, Marc; Mangana, Joanna; Kandolf, Lidija O; Gavrilova, Iva; Ascierto, Paolo Antonio; Gogas, Helen; Rutkowski, Piotr;
Schadendorf, Dirk; Bastholt, Lars; Weichenthal, Michael;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.